{"transactions":[{"id":4626181,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1222,"price":82.2768,"value":100542.2496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $82.08 to $82.56, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23792,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626180,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2270,"price":81.6699,"value":185390.673,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $81.08 to $82.0791, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":25014,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626179,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1325,"price":80.8164,"value":107081.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $80.08 to $81.0769, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":27284,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626178,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":614,"price":79.5114,"value":48819.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.075 to $80.07, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":28609,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626177,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":292,"price":78.1959,"value":22833.2028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.76 to $78.74, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":29223,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":674608,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:42:00.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":1646,"price":63.9664,"value":105288.6944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $63.42 to $64.29, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":29515,"source":{"system":"sec-edgar","filing":"0001610717-26-000389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000389/form4.xml","form_type":"4"}},{"id":674607,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:42:00.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":561,"price":62.7259,"value":35189.2299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $62.26 to $63.23, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":31161,"source":{"system":"sec-edgar","filing":"0001610717-26-000389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000389/form4.xml","form_type":"4"}},{"id":731628,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:08:03.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":364,"price":33.2738,"value":12111.6632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.03 to $33.49, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":31722,"source":{"system":"sec-edgar","filing":"0001610717-26-000242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000242/form4.xml","form_type":"4"}},{"id":731627,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:08:03.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":5359,"price":32.589,"value":174644.451,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.03 to $33.02, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":32086,"source":{"system":"sec-edgar","filing":"0001610717-26-000242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000242/form4.xml","form_type":"4"}},{"id":745755,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:26:38.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":37445,"source":{"system":"sec-edgar","filing":"0001610717-26-000195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000195/form4.xml","form_type":"4"}},{"id":774433,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T22:41:18.000Z","date":"2026-05-14","kind":"grant","planned":true,"acquired":true,"shares":14058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":14058,"derivative":{"exercise_price":25.8,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":14058},"source":{"system":"sec-edgar","filing":"0001713070-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000171307026000002/ownership.xml","form_type":"4"}},{"id":774432,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T22:41:18.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":5740,"price":25.12,"value":144188.8,"ownership":{"direct":true},"balance_after":27951,"source":{"system":"sec-edgar","filing":"0001713070-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000171307026000002/ownership.xml","form_type":"4"}},{"id":774431,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T22:41:18.000Z","date":"2026-05-14","kind":"grant","planned":true,"acquired":true,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":33691,"source":{"system":"sec-edgar","filing":"0001713070-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000171307026000002/ownership.xml","form_type":"4"}},{"id":1120871,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:22:49.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":28616,"source":{"system":"sec-edgar","filing":"0001610717-25-000171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071725000171/form4.xml","form_type":"4"}},{"id":1142067,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-19T22:34:32.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":10787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":10787,"derivative":{"exercise_price":34.84,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":10787},"source":{"system":"sec-edgar","filing":"0000950170-25-074669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025074669/ownership.xml","form_type":"4"}},{"id":1142066,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T22:34:32.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":25940,"source":{"system":"sec-edgar","filing":"0000950170-25-074669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025074669/ownership.xml","form_type":"4"}},{"id":1472848,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T18:22:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":9900,"derivative":{"exercise_price":37.42,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0000950170-24-075483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024075483/ownership.xml","form_type":"4"}},{"id":1472847,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T18:22:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":5345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":20200,"source":{"system":"sec-edgar","filing":"0000950170-24-075483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024075483/ownership.xml","form_type":"4"}},{"id":1480148,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-06-13T20:23:47.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":8649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":13259,"source":{"system":"sec-edgar","filing":"0001610717-24-000327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071724000327/form4.xml","form_type":"4"}},{"id":1851264,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:43:51.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4661,"derivative":{"exercise_price":57.62,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":4661},"source":{"system":"sec-edgar","filing":"0001610717-23-000176","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071723000176/form4.xml","form_type":"4"}},{"id":1851263,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:43:51.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4610,"source":{"system":"sec-edgar","filing":"0001610717-23-000176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071723000176/form4.xml","form_type":"4"}},{"id":1860134,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:30:50.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":7110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":7110,"derivative":{"exercise_price":51.82,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":7110},"source":{"system":"sec-edgar","filing":"0001209191-23-035689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123035689/doc4.xml","form_type":"4"}},{"id":1860133,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T18:30:50.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":3860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":14855,"source":{"system":"sec-edgar","filing":"0001209191-23-035689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123035689/doc4.xml","form_type":"4"}},{"id":2220004,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T17:48:56.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":6245,"derivative":{"exercise_price":60.57,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":6245},"source":{"system":"sec-edgar","filing":"0001209191-22-039562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122039562/doc4.xml","form_type":"4"}},{"id":2220003,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T17:48:56.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":10995,"source":{"system":"sec-edgar","filing":"0001209191-22-039562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122039562/doc4.xml","form_type":"4"}},{"id":2226490,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:16:22.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":5300,"derivative":{"exercise_price":39.62,"expiration_date":"2032-06-15","underlying":"Class A Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001567619-22-013120","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000156761922013120/doc1.xml","form_type":"4"}},{"id":2226489,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T21:16:22.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":2745,"source":{"system":"sec-edgar","filing":"0001567619-22-013120","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000156761922013120/doc1.xml","form_type":"4"}},{"id":2472888,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter."}],"balance_after":305187,"derivative":{"exercise_price":17.23,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472887,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-10","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter."}],"balance_after":380187,"derivative":{"exercise_price":17.23,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472886,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":10898,"price":21.7289,"value":236801.5522,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.565 to $21.92, inclusive."}],"balance_after":102598,"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472885,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":64102,"price":21.1592,"value":1356347.0384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.56 to $21.55, inclusive."}],"balance_after":113496,"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472884,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":75000,"price":17.23,"value":1292250.0,"ownership":{"direct":true},"balance_after":177598,"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472883,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":8874,"price":22.334,"value":198191.916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.205 to $22.54, inclusive."}],"balance_after":102598,"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472882,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":66126,"price":21.6855,"value":1433975.373,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $22.155, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4."}],"balance_after":111472,"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2472881,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-15T01:23:09.000Z","date":"2021-12-10","kind":"exercise","acquired":true,"shares":75000,"price":17.23,"value":1292250.0,"ownership":{"direct":true},"balance_after":177598,"source":{"system":"sec-edgar","filing":"0001209191-21-069643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069643/doc4.xml","form_type":"4"}},{"id":2476754,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-09","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter."}],"balance_after":455187,"derivative":{"exercise_price":17.23,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476753,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":55187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2020."}],"balance_after":134026,"derivative":{"exercise_price":10.24,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":55187},"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476752,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":19813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter."}],"balance_after":530187,"derivative":{"exercise_price":17.23,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":19813},"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476751,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-09","kind":"sale","acquired":false,"shares":2643,"price":23.4043,"value":61857.5649,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.36 to $23.44, inclusive."}],"balance_after":102598,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476750,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-09","kind":"sale","acquired":false,"shares":72357,"price":22.8034,"value":1649985.6138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.36 to $23.35, inclusive."}],"balance_after":105241,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476749,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-09","kind":"exercise","acquired":true,"shares":75000,"price":17.23,"value":1292250.0,"ownership":{"direct":true},"balance_after":177598,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476748,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-08","kind":"sale","acquired":false,"shares":38489,"price":23.0115,"value":885689.6235,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.10, inclusive."}],"balance_after":102598,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476747,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-08","kind":"sale","acquired":false,"shares":36511,"price":22.5583,"value":823626.0913,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.94 to $22.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4."}],"balance_after":141087,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476746,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":55187,"price":10.24,"value":565114.88,"ownership":{"direct":true},"balance_after":177598,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2476745,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-12-11T00:20:00.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":19813,"price":17.23,"value":341377.99,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 755 shares acquired on December 1, 2020 and 1,843 shares acquired on June 1, 2021 pursuant to the Issuer's employee stock purchase plan."}],"balance_after":122411,"source":{"system":"sec-edgar","filing":"0001209191-21-069130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121069130/doc4.xml","form_type":"4"}},{"id":2653127,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T22:22:31.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":4125,"derivative":{"exercise_price":93.2,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-043535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121043535/doc4.xml","form_type":"4"}},{"id":2653126,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T22:22:31.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":2145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":7695,"source":{"system":"sec-edgar","filing":"0001209191-21-043535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121043535/doc4.xml","form_type":"4"}},{"id":2667544,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:54:32.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 11, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1563,"derivative":{"exercise_price":193.51,"expiration_date":"2031-06-11","underlying":"Class A Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-040697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000120919121040697/doc4.xml","form_type":"4"}},{"id":2667543,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-15T21:54:32.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":625,"source":{"system":"sec-edgar","filing":"0001209191-21-040697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000120919121040697/doc4.xml","form_type":"4"}},{"id":2718013,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2021-05-11T22:34:46.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by performance share units, or PSUs. Fifty percent of the award will be earned if the Issuer's average closing stock price is $30 per share for 40 consecutive trading days and an additional fifty percent will be earned if the average closing stock price is $40 per share for 40 consecutive trading days. Upon attainment of the performance metrics, the shares vest in four equal quarterly installments beginning on the first vesting date as set forth in the PSU award agreement."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-21-031839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121031839/doc4.xml","form_type":"4"}},{"id":3012397,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T20:27:41.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":189213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the option shall vest on the one month anniversary of October 1, 2020 (the \"Vesting Commencement Date\"), and one forty-eighth (1/48th) of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a service provider to the Issuer through each such date."}],"balance_after":189213,"derivative":{"exercise_price":10.24,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":189213},"source":{"system":"sec-edgar","filing":"0001209191-20-053599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919120053599/doc4.xml","form_type":"4"}},{"id":3096355,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T17:15:43.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021."}],"balance_after":4250,"derivative":{"exercise_price":76.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-20-039409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120039409/doc4.xml","form_type":"4"}},{"id":3096354,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T17:15:43.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021"}],"balance_after":5550,"source":{"system":"sec-edgar","filing":"0001209191-20-039409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120039409/doc4.xml","form_type":"4"}},{"id":3106223,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-17T20:33:23.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":4432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2020 and each month thereafter, subject to the reporting person continuing as a service provider through each such date."}],"balance_after":4432,"derivative":{"exercise_price":88.42,"expiration_date":"2030-06-15","underlying":"Class A Common Stock","underlying_shares":4432},"source":{"system":"sec-edgar","filing":"0001209191-20-037275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000120919120037275/doc4.xml","form_type":"4"}},{"id":3301048,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-27T22:12:02.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option shall vest on December 9, 2020, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":550000,"derivative":{"exercise_price":17.23,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001209191-20-005031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919120005031/doc4.xml","form_type":"4"}},{"id":3413474,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-16T20:15:20.000Z","date":"2019-09-16","kind":"other","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth of the shares subject to the option vested on September 7, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.  This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."}],"balance_after":100000,"derivative":{"exercise_price":30,"expiration_date":"2029-08-07","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-023627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000089924319023627/doc4.xml","form_type":"4"}},{"id":3413473,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-16T20:15:20.000Z","date":"2019-09-16","kind":"other","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth of the shares subject to the option vested on September 7, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.  This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2029-08-07","underlying":"Class B Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-023627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000089924319023627/doc4.xml","form_type":"4"}},{"id":3490911,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T20:53:02.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":58.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-036829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119036829/doc4.xml","form_type":"4"}},{"id":3490910,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T20:53:02.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-19-036829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119036829/doc4.xml","form_type":"4"}},{"id":3638118,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp Dev & Strategy"}}],"security":"Ordinary Shares","published_at":"2019-02-22T23:23:58.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":5763,"price":27,"value":155601.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,731 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018."}],"balance_after":97198,"source":{"system":"sec-edgar","filing":"0001179110-19-002431","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019002431/edgar.xml","form_type":"4"}},{"id":3679345,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-02T00:25:08.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest with respect to 1/36th of the shares monthly such that the option shall be fully vested on the third anniversary of the grant date."}],"balance_after":20000,"derivative":{"exercise_price":48.85,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-006617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119006617/doc4.xml","form_type":"4"}},{"id":4039499,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp Dev & Strategy"}}],"security":"Ordinary Shares","published_at":"2018-02-22T22:41:37.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":8770,"price":29.09,"value":255119.3,"ownership":{"direct":true},"balance_after":101230,"source":{"system":"sec-edgar","filing":"0001179110-18-002613","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002613/edgar.xml","form_type":"4"}},{"id":4057128,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp Dev & Strategy"}}],"security":"Ordinary Shares","published_at":"2018-02-14T23:23:20.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 1, 2017, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions from August 1, 2017 through December 31, 2020 and continued employment. On February 12, 2018, the performance conditions applicable to 25,000 shares were deemed achieved and such shares will vest on February 20, 2018."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001179110-18-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002128/edgar.xml","form_type":"4"}},{"id":4057127,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp Dev & Strategy"}}],"security":"Ordinary Shares","published_at":"2018-02-14T23:23:20.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001179110-18-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002128/edgar.xml","form_type":"4"}},{"id":4243292,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp Dev & Strategy"}}],"security":"Share Option (Right to Buy)","published_at":"2017-08-03T22:12:42.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised with respect to the first 25% of the shares subject to this option when optionee completes 12 months of continuous service after the Grant Date. This option may be exercised with respect to an additional 1/48th of the shares subject to this option when optionee completes each month of continuous service thereafter. The option shall be fully vested and exercisable on the 4-year anniversary of the Grant Date provided optionee has remained in continuous service through such date."}],"balance_after":170000,"derivative":{"exercise_price":31.93,"expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001179110-17-011060","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017011060/edgar.xml","form_type":"4"}},{"id":4243291,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp Dev & Strategy"}}],"security":"Ordinary Shares","published_at":"2017-08-03T22:12:42.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-17-011060","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017011060/edgar.xml","form_type":"4"}}]}